Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
Cancer remains a significant health challenge globally, with the need for more effective and targeted treatment strategies becoming increasingly urgent. The development of novel drug delivery systems offers promising solutions to enhance the efficacy and specificity of cancer therapies. This thesis focuses on the design and evaluation of advanced drug delivery systems tailored for targeted cancer therapy. The aim is to enhance drug delivery efficiency, reduce off-target effects, and improve patient outcomes. The introductory chapter provides a comprehensive overview of the background and rationale for this research. It highlights the current challenges in cancer treatment, the limitations of existing drug delivery systems, and the potential benefits of targeted drug delivery approaches. The problem statement underscores the critical need for innovative drug delivery systems to overcome the limitations of conventional cancer therapies. The objectives of this study are to design, synthesize, and characterize novel drug delivery systems specifically tailored for targeted cancer therapy. The research methodology chapter outlines the experimental approaches, materials, and techniques employed in the development and evaluation of these drug delivery systems. Key components include formulation design, physicochemical characterization, in vitro and in vivo evaluations, and data analysis methods. The literature review chapter critically examines the existing body of knowledge on drug delivery systems for cancer therapy. It explores the latest advances in nanotechnology, polymer science, and targeting strategies to provide a comprehensive understanding of the field. The discussion of findings chapter presents detailed analyses and interpretations of the experimental results, highlighting the performance and potential applications of the developed drug delivery systems. The significance of this study lies in its potential to advance the field of targeted cancer therapy by introducing innovative drug delivery systems with improved efficacy and safety profiles. The scope of this research encompasses preclinical studies to demonstrate the feasibility and therapeutic potential of the developed drug delivery systems. The limitations of the study are acknowledged, and future research directions are proposed to address these limitations. In conclusion, the development of novel drug delivery systems for targeted cancer therapy represents a significant advancement in the field of oncology. By enhancing the specificity and efficacy of anticancer drugs, these systems have the potential to revolutionize cancer treatment and improve patient outcomes. This thesis contributes to the growing body of knowledge in drug delivery science and offers promising avenues for further research and clinical translation.